Drawing for HARLAN

USPTO serial 88305684

HARLAN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FERRELL, LUCY K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HARLAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David A.W. Wong

David A.W. Wong BARNES & THORNBURG LLP11 SOUTH MERIDIAN STREETINDIANAPOLIS, IN 46204-3535UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
031live laboratory animals; animal feedACTIVE—
042clinical research services in the field of vaccines, biologics, gene therapy, and biopharmaceuticals, pharmacy, medicine, and biology and chemistry, namely, genotyping, zygosity, gene expression, antibody, custom laboratory animal diets, and breeding, namely, collection, calibration, and reporting of data in connection with clinical trials of pharmaceuticals and medical devices; testing and product development of biopharmaceuticals and medical devices; laboratory research in the fields of biology and chemistry, namely, genotyping and phenotyping of animals; Custom design and development of chemical reagents and biochemical assays; laboratory animal scientific research and testing in the fields of pharmacy, medicine, biology and chemistry, namely, genotyping, zygosity, gene expression, antibody, custom laboratory animal diets, and breeding; avian egg development and testing services for the purpose of scientific research and new product research and development; research and development of chemicals, agrochemicals, pharmaceuticals, biologics, vaccines and medical devices; scientific testing of chemicals, agrochemicals, pharmaceuticals, biologics, vaccines, and medical devices; biopharmaceutical research design and scientific testing services; product safety testing for pharmaceuticals, biopharmaceuticals, chemicals, pesticides, medical devices, vaccines, and biologics; toxicological safety testing services for pharmaceuticals, chemicals, agrochemicals, and consumer products; research and scientific testing of pharmaceuticals, biopharmaceuticals, biologics, and medical devices for the presence of endotoxins; animal medical research and testing services in the field vaccines, biologics, gene therapy, and biopharmaceuticals, pharmacy, medicine, and biology and chemistry, namely, genotyping, zygosity, gene expression, antibody, custom laboratory animal diets, and breeding; avian egg development and testing services for the purpose of medical research; Consultation services in the field of providing guidance on scientific research and development for the purposes of providing medical information; laboratory services in the fields of product development and scientific and medical research; Scientific and technological services, namely, scientific testing services in the fields of product development and scientific and medical research; product development services; consulting services for others in the field of scientific and medical research of clinical trials, clinical trial management, and clinical trial recruiting; conducting clinical trials for others; toxicology servicesACTIVE—
044laboratory animal breeding; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals, namely, holding and feeding animals special diets and/or supplements, allowing animals to develop to certain ages before supplying them to customers, performing surgical manipulations on animals and recording and measuring various phenotypic parameters; genetic testing of laboratory animals for research purposes; consulting services in the field of laboratory animal health care, namely, proper utilization of health precautions, the gaps and threats in pathogen targets in healthy panels, interpretation of test results, and the development of custom diet plans; surgery; animal breeding; animal husbandry; genetic testing of animals for diagnostic or treatment purposes; surgery on animals; medical diagnostic testing services, namely, health evaluation of animalsACTIVE—
045reviewing standards and practices to assure compliance with federal food, drug and environmental laws and regulations; reviewing standards and practices to assure compliance with environmental safety laws and regulations; preparing environmental safety compliance reports; reviewing standards and practices to assure compliance with federal agriculture laws and regulations, namely, those relating to laboratory animal scienceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 21, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 21, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 8, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2023EX5GSOU EXTENSION 5 GRANTED—
Feb 7, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 20, 2023EXT5SOU EXTENSION 5 FILED—
Jan 20, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 20, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 18, 2022EX4GSOU EXTENSION 4 GRANTED—
Jul 18, 2022EXT4SOU EXTENSION 4 FILED—
Jul 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2022EX3GSOU EXTENSION 3 GRANTED—
Jan 12, 2022EXT3SOU EXTENSION 3 FILED—
Jan 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 29, 2021DOCKASSIGNED TO EXAMINER—
Jul 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 20, 2021EX2GSOU EXTENSION 2 GRANTED—
Jul 20, 2021EXT2SOU EXTENSION 2 FILED—
Jul 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 25, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2020EX1GSOU EXTENSION 1 GRANTED—
Nov 20, 2020EXT1SOU EXTENSION 1 FILED—
Nov 20, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 21, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 26, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 26, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 6, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 10, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Apr 10, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 10, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 10, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 1, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 1, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 19, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 19, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 19, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2019DOCKASSIGNED TO EXAMINER—
Mar 21, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 21, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance